Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population

Journal of Nephrology

Volumn 23, Issue 3, 2010, Pages 335-340

  Turedi, Suleyman ^a   Cinar, Orhan ^b   Yavuz, Izzet ^b   Mentese, Ahmet ^a   Gunduz, Abdulkadir ^a   Karahan, Suleyman Caner ^a   Topbas, Murat ^a   Cevik, Erdem ^b   Yildirim, Ali Osman ^b   Uzun, Ahmet ^b   Kaldirim, Umit ^b  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

End stage renal disease; Hemodialysis; Ischemia modified albumin; Renal failure

Indexed keywords

ALBUMIN; HEMOGLOBIN; ISCHEMIA MODIFIED ALBUMIN;

ADULT; AGED; ANEMIA; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULONEPHRITIS; HEART RATE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROGENIC BLADDER; RENAL ARTERY ANEURYSM; SYSTOLIC BLOOD PRESSURE; VESICOURETERAL REFLUX;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 77951718884     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sharma R, Gaze DC, Pellerin D, et al. Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease. Clin Sci (Lond). 2007;113:25-32. (Pubitemid 47066022)
2. Robbins MJ, Epstein EM, Shah S. Creatine kinase subform analysis in hemodialysis patients without acute coronary syndromes. Nephron. 1997;76:296-299.
3. Watnick S, Perazella MA. Cardiac troponins: utility in renal insufficiency and end-stage renal disease. Semin Dial. 2002;15:66-70. (Pubitemid 41755932)
4. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med. 2000;19:311-315.
5. Dusek J, St́sek J, Tichý M, et al. Prognostic significance of ischemia-modified albumin after percutaneous coronary intervention. Clin Chim Acta. 2006;367:77-80.
6. Turedi S, Gunduz A, Mentese A, et al. The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism. Respir Res. 2008;9:49.
7. Gunduz A, Turedi S, Mentese A, et al. Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study. Am J Emerg Med. 2008;26:202-205. (Pubitemid 351215796)
8. Gunduz A, Turedi S, Mentese A, et al. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med. 2008;26:874-878.
9. Turedi S, Gunduz A, Mentese A, et al. Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med. 2007;25:770-773. (Pubitemid 47385040)
10. Turedi S, Gunduz A, Mentese A, et al. Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation. Resuscitation. 2009;80:994-999.
11. Montagnana M, Lippi G, Tessitore N, et al. Effect of hemodialysis on traditional and innovative cardiac markers. J Clin Lab Anal. 2008;22:59-65. (Pubitemid 351272482)
12. Tarakçioglu M, Erbagci A, Cekmen M, et al. Acute effect of haemodialysis on serum markers of myocardial damage. Int J Clin Pract. 2002;56:328-332. (Pubitemid 34814582)
13. Lippi G, Tessitore N, Montagnana M, Salvagno GL, Lupo A, Guidi GC. Influence of sampling time and ultrafiltration coefficient of the dialysis membrane on cardiac troponin I and T. Arch Pathol Lab Med. 2008;132:72-76.
14. Sharma R, Gaze DC, Pellerin D, et al. Ischemia-modified albumin predicts mortality in ESRD. Am J Kidney Dis. 2006;47:493-502. (Pubitemid 43255184)
15. Carrega L, Giaime P, Montserrat C, et al. Influence of the dialysis membrane on markers of tissue ischemia. J Investig Med. 2006;54:62-66. (Pubitemid 43352488)
16. Valentini J, Schmitt GC, Grotto D, et al. Human erythrocyte delta-aminolevulinate dehydratase activity and oxidative stress in hemodialysis patients. Clin Biochem. 2007;40:591-594. (Pubitemid 46829072)
17. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart. 2006;92:113-114. (Pubitemid 43021873)
18. Cichota LC, Moresco RN, Duarte MM, da Silva JE. Evalua- tion of ischemia-modified albumin in anaemia associated to chronic kidney disease. J Clin Lab Anal. 2008;22:1-5.